Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Nov;21(6):737-752.
doi: 10.1007/s10741-016-9576-1.

New strategies for improving stem cell therapy in ischemic heart disease

Peisen Huang  1 , Xiaqiu Tian  1 , Qing Li  1 , Yuejin Yang  2
Affiliations
Review

New strategies for improving stem cell therapy in ischemic heart disease

Peisen Huang et al. Heart Fail Rev. 2016 Nov.

Abstract

Stem cell therapy is a promising approach to the treatment of ischemic heart disease via replenishing cell loss after myocardial infarction. Both preclinical studies and clinical trials have indicated that cardiac function improved consistently, but very modestly after cell-based therapy. This mainly attributed to low cell survival rate, engraftment and functional integration, which became the major challenges to regenerative medicine. In recent years, several new cell types have been developed to regenerate cardiomyocytes and novel delivery approaches helped to increase local cell retention. New strategies, such as cell pretreatment, gene-based therapy, tissue engineering, extracellular vesicles application and immunologic regulation, have surged and brought about improved cell survival and functional integration leading to better therapeutic effects after cell transplantation. In this review, we summarize these new strategies targeting at challenges of cardiac regenerative medicine and discuss recent evidences that may hint their effectiveness in the future clinical settings.

Keywords: Exosomes; Ischemic heart disease; MicroRNAs; Stem cell transplantation; Tissue engineering; Transplantation immunology.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nature. 2011 May 13;474(7350):212-5 - PubMed
    1. Biomaterials. 2016 Mar;82:94-112 - PubMed
    1. J Card Fail. 2010 Apr;16(4):357-66 - PubMed
    1. Stem Cells Dev. 2012 May 20;21(8):1321-32 - PubMed
    1. J Am Coll Cardiol. 2011 Jun 14;57(24):2444-52 - PubMed

Publication types

LinkOut - more resources